Bosutinib Tablet, Film Coated
Product Images NDC 62332-311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bosutinib (NDC 62332-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120 Tablets (Bosutinib 100)

120 Tablets (Bosutinib 100)
Label for Bosutinib Tablets 100 mg, film-coated oral tablets manufactured by Alembic Pharmaceuticals Inc. The package contains 120 tablets. Storage instructions, dosage caution, and manufacturer details for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA are included. The label notes the product is for oncology use only and is prescription-only.*
FDA Label Image

30 Tablets (Bosutinib 500)

30 Tablets (Bosutinib 500)
Bosutinib Tablets 500 mg film-coated oral tablet label for a pack of 30 tablets. The label includes storage instructions, manufacturer information for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA, and warnings such as 'Do not crush or cut tablet' and 'For Oncology Use Only.' The NDC is 62332-312-30.*
FDA Label Image

Bosutinib-structure.jpg (Bosutinib Structure)

Bosutinib-structure.jpg (Bosutinib Structure)
Chemical structure of bosutinib showing its molecular framework with two chlorine atoms, methoxy groups, and a piperazine ring. The structure includes aromatic rings and nitrogen atoms consistent with the kinase inhibitor class.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.